Justin D. Gover's Net Worth
$12.1 Million
Who is Justin D. Gover?
Justin D. Gover has an estimated net worth of $12.1 Million. This is based on reported shares across multiple companies, which include GW PHARMACEUTICALS PLC, and Xenon Pharmaceuticals Inc..
SEC CIK
Justin D. Gover's CIK is 0001754129
Past Insider Trading and Trends
2020 was Justin D. Gover's most active year for acquiring shares with 15 total transactions. Justin D. Gover's most active month to acquire stocks was the month of February. 2020 was Justin D. Gover's most active year for disposing of shares, totalling 28 transactions. Justin D. Gover's most active month to dispose stocks was the month of April. 2021 saw Justin D. Gover paying a total of $616.11 for 1,295,436 shares, this is the most they've acquired in one year. In 2021 Justin D. Gover cashed out on 3,173,777 shares for a total of $3,889,392.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GW PHARMACEUTICALS PLC No price found
Chief Executive OfficerJustin D. Gover used to own units in Ordinary Shares but no longer holds any shares there. In the year 2018 Justin D. Gover filed a total of 23 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.55M |
—
|
—
|
0
|
May 5
| |||
Form 4
| -12.88% | -276.00K |
—
|
—
| 1.87M |
Mar 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
| +4,455,360.00% | 222.77K |
$17.90 | -$3,888,776.49 | 222.77K |
Feb 26 - Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
| 456.05K |
Dec 31
| |||
Form 4
|
—
|
0
|
$10.02 | -$1,086,946.04 | 456.05K |
Scheduled
|
Nov 13 - Nov 17
| ||
Form 4
|
—
|
0
|
$10.01 | -$715,630.12 | 456.05K |
Scheduled
|
Nov 9 - Nov 12
| ||
Form 4
| +0.46% | 2.09K |
$10.23 | -$21,232.07 | 456.05K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
| +2.72% | 14.99K |
$8.33 | -$273,727.16 | 566.51K |
Mar 2
| |||
Form 4
| -2.13% | -12.00K |
$9.05 | -$108,558.24 | 551.52K |
Feb 26
| |||
Form 4
|
—
|
0
|
$9.62 | -$1,944,415.35 | 563.52K |
Scheduled
|
Feb 3
| ||
Form 4
| +0.95% | 5.33K |
$9.17 | -$48,953.93 | 563.52K |
Scheduled
|
Dec 17
| ||
Form 4
| +3.08% | 16.66K |
—
| $21.65 | 558.2K |
Jun 14
| |||
Form 4
|
—
|
0
|
$15.24 | -$3,081,541.59 | 541.54K |
Scheduled
|
May 28
| ||
Form 4
| +4.72% | 24.43K |
$14.01 | -$328,035.51 | 541.54K |
Scheduled
|
Mar 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| +3.06% | 11.33K |
$12.45 | -$138,298.91 | 381.77K |
Feb 26
| |||
Form 4
| -5.75% | -22.62K |
$12.50 | -$282,750.00 | 370.44K |
Scheduled
|
Feb 13
| ||
Form 4
| -5.44% | -22.62K |
$8.33 | -$188,406.60 | 393.06K |
Jan 2
| |||
Form 4
| +12.21% | 45.24K |
—
| $58.81 | 415.69K |
Dec 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Xenon Pharmaceuticals Inc. (XENE) Snapshot price: $38.47
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |